US Patent Issued to The Regents of the University of California on Feb. 3 for "Compositions and methods for inhibiting an inflammatory response and treating inflammatory diseases" (California Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,163, issued on Feb. 3, was assigned to The Regents of the University of California (Oakland, Calif.).

"Compositions and methods for inhibiting an inflammatory response and treating inflammatory diseases" was invented by Steven A. Goldstein (Irvine, Calif.) and Ruiming Zhao (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In alternative embodiments, provided are compositions, including products of manufacture and kits, and methods, for inhibiting the ability of neutrophils, or polymorphonuclear leukocytes (PMNs), to release reactive oxygen species (ROS), thus also inhibiting or ameliorating neutrophil (PMN) contribution to an inflammator...